Synonyms: N-(3-Chloropyridin-2-yl)-N-((3R)-piperidin-3-yl)-4-(3H-[1,2,3]triazolo[4,5-b]pyridin-3-yl)benzamide hydrochloride
Molecular Formula: C22H20ClN7O · xHCl
Linear Structural Formula: C22H20ClN7O · xHCl
Purity: >=98% (HPLC)
Storage: room temp
Biochem Physiol Actions: PF-06446846 is a selective orally active PCSK9 inhibitor that appears to act by causing the ribosome to stall when synthesizing PCSK9. PCSK9 binds to the LDL receptor, preventing it from removing LDL cholesterol from the blood. PF-06446846 was found to reduce plasma PCSK9 and total cholesterol levels in rats.
Legal Information: Sold for research purposes under agreement from Pfizer Inc.